Formosa Pharmaceuticals and AimMax Therapeutics announce NDA Submission to USFDA for APP13007
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
The YP-P10 pre-clinical head-to-head study, jointly conducted by five people including Dr. Kyungho Park of Naason Science
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients
Clinical Decision Support Systems' huge potential to help ensure that each patient can receive high-quality care; study shows a reduction in diagnostic errors from 24% to 2%
NGS enables researchers to quickly sequence entire genomes and transcriptomes of organisms.
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
Subscribe To Our Newsletter & Stay Updated